In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Non-Vitamin K Oral Anticoagulants (NOACs) in the “real world” – Opportunities for a differentiated therapy

ACCA webinar

09/01/2017 18:00 09/01/2017 19:00 Europe/Paris Non-Vitamin K Oral Anticoagulants (NOACs) in the “real world” – Opportunities for a differentiated therapy

Access event page

Association for Acute CardioVascular Care contact@escardio.org DD/MM/YYYY
Acute Cardiac Care
Anticoagulants
Cardiovascular Pharmacotherapy
Online
event

Focus on

Learning Objectives

  • Learn or refresh the differences in pharmacodynamics and pharmacokinetics of currently clinically approved NOACs.
  • Learn and interpret real world data on the use of NOACs in patients with AF and concomitant disease. Aspects that may allow a differentiated use of NOACs in these patients.
  • Understand the principles of reversal agents in patients with severe bleeding on NOAC therapy. Learn the appropriate clinical use of the first approved NOAC antidote idaracuzimab.
  • Learn about the emergency situations which may and which may not require NOAC reversal. Understand the issue of long-term therapy after an acute sever bleeding event in patients on NOAC therapy.